Immunotherapy

Mayo Clinic's #1-ranked mesothelioma program delivers multidisciplinary treatment with access to clinical trials across Rochester, Phoenix, and Jacksonville locations.

FDA-approved immunotherapy drugs Keytruda and Opdivo are transforming mesothelioma treatment. Learn how checkpoint inhibitors work, who qualifies, and what results patients are seeing in 2026.

56+ active mesothelioma clinical trials offer access to breakthrough treatments in 2026. Learn about immunotherapy, CAR T-cell therapy, and targeted treatments that are quadrupling survival rates.